Table 1.
MSC SOURCE MODULATION IN VITRO | |||||
---|---|---|---|---|---|
MSC source | Macrophage source | Induction | Implicated mediator | Macrophage activation state | References |
Murine BM-MSCs | Murine BM | M-CSF | ND | IL-10highiNOS activitydown/Arg activityup | Cho et al., 2014 |
Murine BM-MSCs | Murine BM | M-CSF | PGE2 | IL-10highTNF-αlow | Kudlik et al., 2016 |
Murine BM-MSCs | Peritoneal macrophages | Thioglycollate | PGE2 | IL-10highIL-12p40highIL-6lowTNF-αlow | Maggini et al., 2010 |
Murine ASCs and conditioned media | Murine BM | M-CSF | PGE2 | IL-10highArg activityupLIGHT+ | Anderson et al., 2013b |
Human BM-MSCs | Human CD14+ blood monocytes | IDO | IL-10highCD206+ | François et al., 2012 | |
Human BM-MSCs | PBMCs | M-CSF | PGE2 | IL-10int/TNF-αlow/IL-6low/TGF-βhigh/DC-SIGNint/CD206int | Vasandan et al., 2016 |
Human BM-MSCs | Human CD14+ blood monocytes | ND | IL-10highCCL18+ CD206+CD163+ | Melief et al., 2013a | |
Human BM-MSCs | Human CD14+ blood monocytes | M-CSF | ND | IL-10highCD206+ | Chiossone et al., 2016 |
Human amniotic MSCs (and their CM) | Human CD14+ blood monocytes | GM-CSF | PGE2 | IL-10highCD206+DC-SIGN+ | Magatti et al., 2017 |
Murine ASC-derived exosomes | Murine BM | L929 CM (30%) | ND | IL-10highCD206+IL-6lowiNOS activitydown/ArgI activityup | Henao Agudelo et al., 2017 |
Human ASC-derived exosomes | Murine BM | GM-CSF | ND | CD206+CD36+CD86−CD40− | Lo Sicco et al., 2017 |
Human UC-MSC-derived exosomes | Peritoneal macrophages | ND | IL-10highTNF-αlowIL-6low(qPCR)IL-7low | Mao et al., 2017a | |
Human UC-MSC-derived exosomes | Murine BM | M-CSF | miR-146a | IL-10highArgI+TNF-αlowiNOSlow | Song Y. et al., 2017 |
MACROPHAGE MODULATION IN VIVO | |||||
MSCs source | Animal model | Administration | Implicated mediator | Macrophage activation state | References |
Murine BM-MSCs | DSS colitis | i.p. 3 × 106 cells on day 5 | TSG-6 | ArgII+CCL22+HO-1+TNF-αlow IL-12low | Sala et al., 2015 |
Murine BM-MSCs | DSS colitis | i.v. 1 × 106 cells on day 8 | ND | F4/80+CD206+ | Wang et al., 2014 |
Murine ASCs | DSS colitis | i.p. 1 × 106 cells on day 1 and 5 | ND | ArgI increased in colon (protein and mRNA) | de Aguiar et al., 2018 |
Murine BM- MSCs | DSS colitis | i.p. 0.5 × 106 cells on day 0 and 12 | Knock down of gal-3 | IL-10highIL-12low F4/80+CD206+ | Markovic et al., 2015 |
Murine BM-MSCs | TNBS colitis | i.v. 1 × 106 cells on day 0 | ND | CD11b+splenic macrophages | Parekkadan et al., 2011 |
Human ASCs | DSS colitis | i.p. 2 × 106 cells on day 1 | TSG-6 | CD206+ArgI+/ym1+/Fizz1+ | Song W. J. et al., 2017 |
Human UC-MSC extracts | DSS colitis | i.p. 150μg/mouse on day 3 | ND | ArgI+LIGHT+CCL1+ in peritoneal macrophages | Song J. et al., 2017 |
INHIBITION OF MONOCYTE TO iDC DIFFERENTIATION | |||||
MSC source | Macrophage source | iDC induction | Implicated mediator | Macrophage activation state | References |
Human BM-MSCs | Human CD14+ blood monocytes | IL-4+ GM-CSF | IL-6 | CD14+CD1a−IL-10high | Melief et al., 2013a |
Human UC-MSCs | Human CD14+ blood monocytes | IL-4+ GM-CSF | Lactate | CD14+CD1a−IL-10highTGF-β1+IL-6+ | Selleri et al., 2016 |
Human UC-MSC | Human CD14+ blood monocytes | IL-4+ GM-CSF | IL-6, HGF | CD14+CD1a−IL-10highIL-12low | Deng et al., 2016 |
ND, not determined; Gal-3, galectin-3; Arg, arginase; i.p., intraperitoneal; i.v., intravenous; PBMCs, peripheral blood mononuclear cells; BM, bone marrow; UC, umbilical cord; CM, conditioned medium; CD163, hemoglobin scavenger receptor; LIGHT, TNF superfamily member 14; DC-SIGN, CD209/dendritic cell-specific intercellular adhesion molecule-3-grabbing non-integrin; CCL1, C-C motif chemokine ligand 1; CCL18, C-C motif chemokine ligand 18; CCL22, C-C motif chemokine ligand 22; HO-1, heme oxygenase-1; ym1, chitinase-3-like protein 3; Fizz1, found in inflammatory zone 1; IDO, indolamine 2,3,-dioxygenase.